Generalizability of predictive versus prognostic indicators from published transcriptomic associations with tumor response to immune checkpoint inhibition
Bortone, D. ; Monette, A. ; Tschernia, N. ; Cogdill, A. ; Najjar, Y. ; Sweis, R. F. ; Valpione, Sara ; Wennerberg, E. ; Bommareddy, P. ; Haymaker, C. ... show 10 more
Bortone, D.
Monette, A.
Tschernia, N.
Cogdill, A.
Najjar, Y.
Sweis, R. F.
Valpione, Sara
Wennerberg, E.
Bommareddy, P.
Haymaker, C.
Citations
Altmetric:
Abstract
Authors
Bortone, D.
Monette, A.
Tschernia, N.
Cogdill, A.
Najjar, Y.
Sweis, R. F.
Valpione, Sara
Wennerberg, E.
Bommareddy, P.
Haymaker, C.
Khan, U.
McGee, H. M.
Park, W.
Sater, H. A.
Spencer, C.
Ascierto, M.
Barsan, V.
Popat, V.
Wells, D.
Vensko, S.
Dexheimer, S.
Thorsson, V.
Zappasodi, R.
Rudqvist, N. P.
Vincent, B.
Monette, A.
Tschernia, N.
Cogdill, A.
Najjar, Y.
Sweis, R. F.
Valpione, Sara
Wennerberg, E.
Bommareddy, P.
Haymaker, C.
Khan, U.
McGee, H. M.
Park, W.
Sater, H. A.
Spencer, C.
Ascierto, M.
Barsan, V.
Popat, V.
Wells, D.
Vensko, S.
Dexheimer, S.
Thorsson, V.
Zappasodi, R.
Rudqvist, N. P.
Vincent, B.
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Bortone D, Monette A, Tschernia N, Cogdill A, Najjar Y, Sweis RF, et al. Generalizability of Predictive Versus Prognostic Indicators from Published Transcriptomic Associations with Tumor Response to Immune Checkpoint Inhibition. Journal for immunotherapy of cancer. 2022 Nov;10:A531-A2. PubMed PMID: WOS:000919423400487.